Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Commandité

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Posté

53

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Connectez-vous pour aimer, partager et commenter!

Family Trifecta: 3 officers in Army, Navy, IAF

Par 0 6

Israel and Iran exchange fresh strikes amid rising regional tensions

TEL AVIV: Israel and Iran engaged in a new round of attacks on each other overnight into Sunday,...

Par 0 6

Widespread rain reported across Nepal, including Kathmandu

KATHMANDU: Rainfall is occurring in several parts of the country, including the Kathmandu Valley,...

Par 0 7

Legislative Management Committee meeting taking place today

KATHMANDU: The Legislative Management Committee of the National Assembly is holding a meeting on...

Par 0 14

Kartik's B'day wish for Sreeleela fuels romance buzz

Kartik Aaryan's playful birthday wish to Sreeleela, calling her "Monkey Face," has ignited...

Par 0 19